CALCOCO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.98500002282998E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.21110000203839E-08 |
Normal-vs-Stage2 |
2.32109999999119E-05 |
Normal-vs-Stage3 |
1.73429999994479E-06 |
Normal-vs-Stage4 |
5.77160000014842E-07 |
Stage1-vs-Stage2 |
7.841600E-01 |
Stage1-vs-Stage3 |
3.037400E-01 |
Stage1-vs-Stage4 |
2.104000E-01 |
Stage2-vs-Stage3 |
5.265800E-01 |
Stage2-vs-Stage4 |
2.270800E-01 |
Stage3-vs-Stage4 |
5.135200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.97570004590153E-09 |
Normal-vs-AfricanAmerican |
2.38710000000086E-05 |
Normal-vs-Asian |
1.129580E-01 |
Caucasian-vs-AfricanAmerican |
5.668200E-01 |
Caucasian-vs-Asian |
5.319400E-01 |
AfricanAmerican-vs-Asian |
4.057600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.17910000044341E-08 |
Normal-vs-Female |
6.32590000049227E-07 |
Male-vs-Female |
5.959000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.24409999996611E-06 |
Normal-vs-Extreme_Weight |
2.88100000522817E-08 |
Normal-vs-Obese |
1.15930000044173E-07 |
Normal-vs-Extreme_Obese |
1.41190000002567E-06 |
Normal_Weight-vs-Extreme_Weight |
7.773600E-01 |
Normal_Weight-vs-Obese |
5.915600E-01 |
Normal_Weight-vs-Extreme_Obese |
6.100000E-01 |
Extreme_Weight-vs-Obese |
7.702800E-01 |
Extreme_Weight-vs-Extreme_Obese |
4.693600E-01 |
Obese-vs-Extreme_Obese |
3.198600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.031820E-02 |
Normal-vs-Age(41-60Yrs) |
4.413400000014E-06 |
Normal-vs-Age(61-80Yrs) |
1.6493999499545E-09 |
Normal-vs-Age(81-100Yrs) |
7.781000E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.601800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.096000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.869400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.282000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.801000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.093200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.810760E-04 |
Normal-VS-Type2 PRCC |
1.66122671174662E-12 |
Normal-VS-KIRP CIMP |
5.52439999967902E-07 |
Normal-VS-Unclassified PRCC |
8.225400E-04 |
Type1 PRCC-VS-Type2 PRCC |
3.08419999539566E-08 |
Type1 PRCC-VS-KIRP CIMP |
3.540600E-03 |
Type1 PRCC-VS-Unclassified PRCC |
2.661600E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.625400E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.934110E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.180440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.56319999459143E-08 |
Normal-vs-N1 |
1.224450E-04 |
Normal-vs-N2 |
6.11480000000109E-05 |
N0-vs-N1 |
8.381000E-01 |
N0-vs-N2 |
4.079000E-01 |
N1-vs-N2 |
3.578600E-01 |
|
|